Abbott Whistleblower Seeks New Trial In $219M Stent Row
The whistleblower who accused Abbott Laboratories of improperly marketing bile duct stents for off-label use asked a Texas federal judge Friday to grant a new trial after a jury in April...To view the full article, register now.
Already a subscriber? Click here to view full article